Published in J Exp Med on February 01, 1973
Lymphocyte transformation induced by autologous cells. IV. Human T-lymphocyte proliferation induced by autologous or allogeneic non-T lymphocytes. J Exp Med (1976) 4.63
T and B cell in hapten-specific carrier-determined tolerance. J Exp Med (1975) 1.03
Studies on the cytotoxic effect of in vivo and in vitro immunized lymphocytes on liver target cells. Clin Exp Immunol (1975) 1.01
Identification of a subpopulation of lymphocytes in human peripheral blood cytotoxic to autologous fibroblasts. J Exp Med (1976) 0.97
Induction of tolerance in vitro by autologous murine testicular cells. J Exp Med (1980) 0.87
Myelin basic protein serum factor. An endogenous neuroantigen influencing development of experimental allergic encephalomyelitis in Lewis rats. J Exp Med (1978) 0.82
Increased incidence of urethane induced lung adenomata by autosensitized lymphocytes. Br J Cancer (1974) 0.82
Factors influencing the autologous mixed lymphocyte reaction in rats: effect of xenogeneic serum protein. Immunology (1981) 0.81
Maintenance of immunologic self-tolerance by nonimmunogenic forms of antigen. Clin Exp Immunol (1976) 0.79
Mixed lymphocyte reactivity against normal cells by splenic lymphocytes from tumor-bearing mice : ii. Studies of autoimmune-like activity in completely syngeneic and semisyngeneic systems. J Exp Med (1974) 0.75
The somatic generation of immune recognition. Eur J Immunol (1971) 6.80
A lymph node weight assay for the graft-versus-host activity of rat lymphoid cells. Transplantation (1970) 4.35
Kinetic differences in unresponsiveness of thymus and bone marrow cells. Science (1971) 4.13
Suppressor T cells. J Immunol (1972) 3.92
Quantitative studies on the mixed lymphocyte interaction in rats. II. Relationship of the proliferative response to the immunologic status of the donors. J Exp Med (1967) 3.82
Antigen binding cells in tolerance and immunity. Transplant Rev (1970) 3.08
The role of lymphocytes in antibody formation. I. Restoration of the haemolysin response in x-irradiated rats with lymphocytes from normal and immunologically tolerant donors. Proc R Soc Lond B Biol Sci (1967) 2.86
Recent observations and concepts in immunological unresponsiveness and autoimmunity. Clin Exp Immunol (1971) 2.45
Genetic and immunological complexity of major histocompatibility regions. Science (1972) 2.40
Antibody-mediated suppression of the immune response in vitro. I. Evidence for a central effect. J Exp Med (1970) 2.17
Cellular and humoral response to transplantation antigens. I. Development of alloantibody-forming cells and cytotoxic lymphocytes in the graft-versus-host reaction. J Exp Med (1971) 2.13
Graft versus host reaction in tissue culture. I. Lysis of monolayers of embryo mouse cells from strains differing in the H-2 histocompatibility locus by rat lymphocytes sensitized in vitro. Immunology (1968) 2.04
Graft reaction in tissue culture. II. Quantification of the lytic action on mouse fibroblasts by rat lymphocytes sensitized on mouse embryo monolayers. Immunology (1969) 1.93
Regulation of antibody response by cells expressing histamine receptors. J Exp Med (1972) 1.70
Immunological tolerance: "forbidden clones" allowed in tetraparental mice. Proc Natl Acad Sci U S A (1971) 1.67
Lymphocyte membrane dynamics. Metabolic release of cell surface proteins. J Exp Med (1971) 1.60
Rapid breaking of tolerance against Escherichia coli lipopolysaccharide in vivo and in vitro. J Exp Med (1972) 1.40
Glucocorticoids and cellular immunity in vitro. Facilitation of the sensitization phase and inhibition of the effector phase of a lymphocyte anti-fibroblast reaction. J Exp Med (1970) 1.37
Autosensitization in vitro. J Exp Med (1971) 1.33
Fractionation of antigen reactive cells on a cellular immunoadsorbent: factors determining recognition of antigens by T-lymphocytes. Proc Natl Acad Sci U S A (1972) 1.31
Responsiveness of thymus cells to syngeneic and allogeneic lymphoid cells. Nat New Biol (1972) 1.22
Autologous and allogeneic stimulation of peripheral human leukocytes. Cell Immunol (1972) 1.18
Fractionation of specific antigen-reactive cells in an in vitro system of cell-mediated immunity. Nat New Biol (1972) 1.17
Induction and reversal of immune paralysis in vitro. J Exp Med (1970) 1.16
Aliotypic antibodies. Transplant Rev (1972) 1.15
Binding of 125I-BSA to lymphoid cells of tolerant mice. Int Arch Allergy Appl Immunol (1969) 1.13
Autosensitization of lymphocytes against thymus reticulum cells. Science (1972) 1.13
Immune status of mice tolerant of living cells. II. Continuous presence and nature of facilitation-enhancing antibodies in tolerant animals. J Exp Med (1972) 1.12
The lysis of fibroblasts by lymphocytes sensitized in vitro: specific antigen activates a nonspecific effect. Cell Immunol (1970) 1.10
Antigen-binding cells in mice immune or tolerant to Escherichia coli polysaccharide. J Exp Med (1971) 1.04
Quantitative study of cells reacting to skin allografts. Nature (1970) 0.97
Soluble adherent cell activity permitting purified lymphocyte response. Transplant Proc (1971) 0.78
Neisseria gonorrhoeae. II. Colonial variation and pathogenicity during 35 months in vitro. J Bacteriol (1968) 16.77
Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature (1988) 6.18
The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol (1981) 3.96
Competition between, and effectiveness of, IgG and IgM antibodies in indirect fluorescent antibody and other tests. J Immunol (1967) 3.72
Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature (1984) 3.71
Natural and immune human antibodies reactive with antigens of virulent Neisseria gonorrhoeae: immunoglobulins G, M, And A. J Bacteriol (1967) 3.56
Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci U S A (1985) 3.31
Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. Lancet (2001) 3.26
T lymphocytes of rheumatoid arthritis patients show augmented reactivity to a fraction of mycobacteria cross-reactive with cartilage. Lancet (1986) 3.20
Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med (1999) 3.13
Natural human antibodies to gram-negative bacteria: immunoglobulins G, A, and M. Science (1966) 3.00
Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science (1983) 2.96
Induction of MHC class I genes in neurons. Science (1995) 2.84
Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med (1999) 2.84
Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity (2001) 2.77
Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II. J Clin Invest (1984) 2.66
Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Nature (1981) 2.44
Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobacteria in early chronic arthritis. Lancet (1988) 2.43
Peptide therapy for diabetes in NOD mice. Lancet (1994) 2.28
Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J Immunol (2001) 2.27
Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc Natl Acad Sci U S A (1990) 2.23
Thymic nurse cells. Lymphoepithelial cell complexes in murine thymuses: morphological and serological characterization. J Exp Med (1980) 2.23
Serum antibody response in experimental human gonorrhoea. Immunoglobulins G, A, and M. Br J Vener Dis (1969) 2.17
Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. Science (1988) 2.16
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology (2011) 2.07
T lymphocyte clones illuminate pathogenesis and affect therapy of experimental arthritis. Arthritis Rheum (1985) 2.06
T lymphocyte line specific for thyroglobulin produces or vaccinates against autoimmune thyroiditis in mice. J Immunol (1983) 2.05
Antibiodies of the IgG, IgM, and IgA classes in newborn and adult sera reactive with gram-negative bacteria. J Clin Invest (1968) 1.98
Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc Natl Acad Sci U S A (1991) 1.97
Constitutive NF-kappa B activity in neurons. Mol Cell Biol (1994) 1.96
Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. Proc Natl Acad Sci U S A (1990) 1.93
Astrocytes as antigen-presenting cells. I. Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation. J Immunol (1985) 1.88
The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem J (1994) 1.87
B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J Exp Med (1998) 1.85
Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: process of selection of lines and characterization of the cells. J Immunol (1982) 1.84
Thymic nurse cells--Ia-bearing epithelium involved in T-lymphocyte differentiation? Nature (1980) 1.83
Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis (1992) 1.79
The distribution of Ia antigen in the lesions of rat acute experimental allergic encephalomyelitis. Acta Neuropathol (1986) 1.77
T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur J Immunol (1993) 1.74
Immune information, self-organization and meaning. Int Immunol (1998) 1.73
Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions. Nature (1988) 1.71
Antigen microarrays identify CNS-produced autoantibodies in RRMS. Neurology (2012) 1.67
Low-dose low-molecular-weight heparin (enoxaparin) is beneficial in lichen planus: a preliminary report. J Am Acad Dermatol (1998) 1.64
Protective autoimmunity is a physiological response to CNS trauma. J Neurosci (2001) 1.64
Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J Neurosci (2000) 1.62
T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc Natl Acad Sci U S A (2000) 1.61
Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology (1990) 1.61
Binding of anti-DNA antibodies and inhibition of glomerulonephritis in MRL-lpr/lpr mice by heparin. Arthritis Rheum (1990) 1.60
Thymus-derived lymphocytes: humoral and cellular reactions distinguished by hydrocortisone. Science (1972) 1.58
T lymphocyte lines producing or vaccinating against autoimmune encephalomyelitis (EAE). Functional activation induces peanut agglutinin receptors and accumulation in the brain and thymus of line cells. Eur J Immunol (1983) 1.58
Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity. Hepatology (1990) 1.57
Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells. Science (1989) 1.56
Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells. Proc Natl Acad Sci U S A (2000) 1.53
Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells. Ann Neurol (1995) 1.50
Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am J Pathol (1993) 1.50
Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab Invest (1997) 1.47
Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat Med (1996) 1.47
Neurotrophins inhibit major histocompatibility class II inducibility of microglia: involvement of the p75 neurotrophin receptor. Proc Natl Acad Sci U S A (1998) 1.47
Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: epitope spreading versus clonal persistence. Brain (2000) 1.47
Detection of DNA fragmentation in apoptosis: application of in situ nick translation to cell culture systems and tissue sections. J Histochem Cytochem (1993) 1.44
Innate and adaptive immune responses can be beneficial for CNS repair. Trends Neurosci (1999) 1.44
Autoantibodies to insulin receptor spontaneously develop as anti-idiotypes in mice immunized with insulin. Science (1982) 1.44
Effector T lymphocyte line cells migrate to the thymus and persist there. Nature (1982) 1.44
Idiotypic immunization induces immunity to mutated p53 and tumor rejection. Nat Med (1998) 1.43
Transformation of thymocytes by thymus epithelium derived from AKR mice. Nature (1976) 1.43
Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase. Nature (1984) 1.42
Gene transfer into CD4+ T lymphocytes: green fluorescent protein-engineered, encephalitogenic T cells illuminate brain autoimmune responses. Nat Med (1999) 1.42
Regulation of autoimmune disease physiological and therapeutic. Immunol Rev (1986) 1.41
Diversity of the anti-T-cell receptor immune response and its implications for T-cell vaccination therapy of multiple sclerosis. Brain (1998) 1.41
Human myoblasts as antigen-presenting cells. J Immunol (1992) 1.39
Low doses of low molecular weight heparin in vivo inhibits the elicitation of contact hypersensitivity. Acta Derm Venereol (1994) 1.39
Borna disease, a progressive meningoencephalomyelitis as a model for CD4+ T cell-mediated immunopathology in the brain. J Exp Med (1989) 1.39
Glucocorticoids and cellular immunity in vitro. Facilitation of the sensitization phase and inhibition of the effector phase of a lymphocyte anti-fibroblast reaction. J Exp Med (1970) 1.37
Autosensitization in vitro. J Exp Med (1971) 1.33
Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes. Nature (1986) 1.33
Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia. J Exp Med (1994) 1.33
Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity. J Autoimmun (2000) 1.32
Therapeutic vaccination against adjuvant arthritis using autoimmune T cells treated with hydrostatic pressure. Proc Natl Acad Sci U S A (1987) 1.31
Fractionation of antigen reactive cells on a cellular immunoadsorbent: factors determining recognition of antigens by T-lymphocytes. Proc Natl Acad Sci U S A (1972) 1.31
Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice: modulation of spontaneous 60-kDa heat shock protein autoimmunity. J Immunol (2000) 1.30
Mechanisms of action of glatiramer acetate in multiple sclerosis. Neurology (2001) 1.30
Interferon gamma gene expression in sensory neurons: evidence for autocrine gene regulation. J Exp Med (1997) 1.29
Immunological update on multiple sclerosis. Curr Opin Neurol (2001) 1.28
Intrathymic pathogenesis and dual genetic control of myasthenia gravis. Lancet (1977) 1.27
Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors. Am J Pathol (1988) 1.27
Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes. Am J Pathol (2001) 1.26
Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species. Blood (1987) 1.26
T lymphocyte lines induce autoimmune encephalomyelitis, delayed hypersensitivity and bystander encephalitis or arthritis. Eur J Immunol (1984) 1.25
Spontaneous remission and acquired resistance to autoimmune encephalomyelitis (EAE) are associated with suppression of T cell reactivity: suppressed EAE effector T cells recovered as T cell lines. J Immunol (1982) 1.24
Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. J Clin Invest (1996) 1.24
Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens. Diabetes (1997) 1.24
Neuronal control of the immune response in the central nervous system: linking brain immunity to neurodegeneration. J Neuropathol Exp Neurol (1998) 1.22
Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity. Eur J Immunol (1990) 1.22
Cell-free media of mixed lymphocyte cultures augmenting sensitization in vitro of mouse T lymphocytes against allogeneic fibroblasts. Eur J Immunol (1976) 1.22
Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. J Clin Invest (1988) 1.21
A permanent rat T cell line that mediates experimental allergic neuritis in the Lewis rat in vivo. J Immunol (1984) 1.21
Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix. J Cell Physiol (1987) 1.19